Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

WHN Forum background globe
Forums
Turbo Cancers and A...
Turbo Cancers and A...
ASCO 2026: Dynamic ...
 
Notifications
Clear all

ASCO 2026: Dynamic Therapy Interventions With PSMA in Metastatic HSPC

 
Turbo Cancers and Alternate Cancer Treatment
Last Post by Anonymous 2 weeks ago
1 Posts
1 Users
0 Reactions
23 Views
Solved
RSS
 Dr. Larsen
(@Dr. Larsen)
Joined: 4 weeks ago
Posts: 6
Topic starter 02/06/2026 10:01 pm  

Leveraging 6-month PSA and PSMA-PET metrics may guide therapy escalation or de-escalation in metastatic hormone-sensitive prostate cancer.

https://www.cancernetwork.com/view/asco-2026-dynamic-therapy-interventions-with-psma-in-metastatic-hspc



   
Quote
Topic Tags
prostate cancer metastatic asco 2026 2026 dynamic dynamic therapy

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved
Forum Jump:
  Previous Topic
Next Topic  
Related Topics
Topic Tags:  prostate cancer (96) , metastatic (98) , asco 2026 (1) , 2026 dynamic (1) , dynamic therapy (1) ,